K-Stem Cell, registers a patent for the manufacturing of stem cells appropriate for intravascular administration

K-Stem Cell, registers a patent for the manufacturing of stem cells appropriate for intravascular administration

K-Stem Cell (formerly, RNL Bio), a bioscience enterprise, announced that the patent for the “method of manufacturing stem cells in an appropriate size for intravascular administration(Patent Application No. 10-2012-0040488),” for which the application process was completed in 2012, was accepted for registration by the Korean Intellectual Property Office (KIPO) on November 20, 2014.

Read more